A recent shortage in Adderall comes after a large spike in demand for the prescription drug, with many prescriptions being issued from telehealth startups earlier this year. These platforms that emerged during the pandemic have raised concerns regarding the overprescription of controlled substances. However, the high amount of prescriptions coming from these newer companies follows a longstanding trend of potential ADHD overdiagnosis and overtreatment in the US.
View More How Telehealth Contributed to the Adderall Shortage and Reignited Concerns